Studies have also shown that low ASS1 expression is associated with poor prognosis and resistance to conventional chemotherapy in various types of cancer, indicating that alternative therapeutic strategies such as arginine deprivation therapy may be necessary for these patients [21,34,52,54,176]. The gene discussed is ASS1; the disease is cancer.